Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Items 801–900 of 1,001
The Physics of the Interactions Governing Folding and Association of Proteins
Guo, W., Shea, J., & Berry, R. S. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1363.025 · Cited by 23
Kim, B., Park, H., Lee, S. K., Park, S. J., Koo, T., Kang, N. S., Hong, K. B., & Choi, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.003 · Cited by 18
PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity
Mengel, D., Hong, W., Corbett, G. T., Liu, W., DeSousa, A., Solforosi, L., Fang, C., Frosch, M. P., Collinge, J., Harris, D. A., et al. (2018) · Brain Research · doi:10.1016/j.brainres.2018.12.038 · Cited by 18
“A hallmark of disorders such as Alzheimer’s disease (AD), Parkinson’s disease and transmissible spongiform encephalopathies (TSEs) is the presence of aggregates formed from neuronal proteins of unrelated sequences (Selkoe, 2003; Silveira et al., 2005; Soto, 2003; Walsh and Selkoe, 2016).”
BackgroundLaos, V., Bishop, D., Ganguly, P., Schonfeld, G. E., Trapp, E., Cantrell, K. L., Buratto, S. K., Shea, J., & Bowers, M. T. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c12729 · Cited by 20
Dyakin, V. V., Wısnıewskı, T., & Lajtha, Á. (2021) · Symmetry · doi:10.3390/sym13030455 · Cited by 20
“In the brain of AD individuals, the chain of Aβ peptide structural transitions is initiated by the monomer to oligomer transition followed by the protofibrils, fibrils, and plaques formation [3,421].”
BackgroundLashley, T., Tossounian, M., Heaven, N. C., Wallworth, S., Peak‐Chew, S., Bradshaw, A., Cooper, J. A. D., de Silva, R., Srai, S. K., Malanchuk, O., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.739425 · Cited by 20
“Leading to cellular dysfunction, synaptic damage and neuronal death, aberrant protein aggregation in the brain is one of the main events in brain disease pathology (Soto, 2003; Ross and Poirier, 2004; Goedert, 2015).”
BackgroundKhan, M. S., Althobaiti, M. S., Almutairi, G. S., Alokail, M. S., Altwaijry, N. A., Alenad, A. M. H., Al-Bagmi, M. S., & Alafaleq, N. O. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106823 · Cited by 18
Guzzo, A., Delarue, P., Rojas, A. V., Nicolaï, A., Maisuradze, G. G., & Senet, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.910104 · Cited by 18
“In synucleopathies (Soto, 2003; Chiti and Dobson, 2006; Stefanis, 2012; Chiti and Dobson, 2017; Tanudjojo et al., 2021), such as the Parkinson disease (PD), α-syn is found in high concentration, as filamentous aggregates, in intraneuronal inclusions (Lewy bodies) and in extracellular deposits (Lewy neurites) (Spillant…”
BackgroundHerrera, M. I., Udovin, L., Toro-Urrego, N., Kusnier, C. F., Luaces, J. P., Losada, M. E. O., & Capani, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00339 · Cited by 20
“The deposition and accumulation of misfolded proteins is a common sign in many neurodegenerative diseases, characterized by cell signaling impairment and defective neuronal connectivity following cell death (Soto, 2003).”
BackgroundHierarchy and the mechanism of fibril formation in ADan peptides
Surolia, I., Reddy, G. B., & Sinha, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04072.x · Cited by 18
“In time, these structures are either ubiquitinated or form insoluble deposits, like those of amyloid fibrils, which are the hallmark of most neurodegenerative diseases (Horwich and Weissman 1997; Dobson 1999; Soto 2003; Agorogiannis et al. 2004; Foguel and Silva 2004; Ross and Pickart 2004).”
BackgroundGupta, V. B., Hegde, M. L., & Rao, K. S. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249452 · Cited by 19
“Although, there are several evidences to support the fact that the molecular cause of neurodegenerative diseases is the accumulation of mis-folded and aggregated protein, according to Soto, 2003, [46] the final proof of this hypothesis would be a possible cure of the disease in humans by arresting or reversing the pro…”
BackgroundInfluentialNiu, F., Sharma, A., Wang, Z., Feng, L., Muresanu, D. F., Sahib, S., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., et al. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.09.011 · Cited by 17
Ruan, C., Kong, J., He, X., Hu, B., & Zeng, X. (2022) · Food Materials Research · doi:10.48130/fmr-2022-0002 · Cited by 20
Transmission of Cerebral β-Amyloidosis Among Individuals
Hamaguchi, T., Ono, K., & Yamada, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03566-4 · Cited by 17
“1 3 Huntington’s disease, and amyotrophic lateral screlosis (ALS), are also considered to be caused by changing the three-dimensional structure (conformation) and misfolding of specific proteins like prion disease, which is so called protein conformational disease [4].”
BackgroundHe, C., Tang, Y., Chen, X., Long, T., He, Y.-N., Wei, J., Wu, J., Lan, C., Yu, L., Huang, F., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154548 · Cited by 19
Label-free identification of protein aggregates using deep learning
Ibrahim, K. A., Grußmayer, K. S., Riguet, N., Feletti, L., Lashuel, H. A., & Rađenović, A. (2023) · Nature Communications · doi:10.1038/s41467-023-43440-7 · Cited by 18
Neuroinflammation as a therapeutic target in neurodegenerative diseases
Gordon, R., & Woodruff, T. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00003-8 · Cited by 25
Gupta, A., & Mahalakshmi, R. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201812272 · Cited by 18
“201812272 501 VDAC aggregation proceeds likely through structured oligomers How do VDACs aggregate? Aggregation largely follows protein unfolding; however, folded proteins can also aggregate by oligomerization (Soto, 2003).”
BackgroundWardman, J. H., Henriksen, E. E., Marthaler, A. G., Nielsen, J. E., & Nielsen, T. T. (2020) · The Cerebellum · doi:10.1007/s12311-019-01092-8 · Cited by 17
“This could result in cell death due to the aggregates themselves [63] and increased ROS from un-degraded, damaged mitochondria [64].”
Photoresponsive Prion‐Mimic Foldamer to Induce Controlled Protein Aggregation
Marafon, G., Crisma, M., Masato, A., Plotegher, N., Bubacco, L., & Moretto, A. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202012995 · Cited by 17
Li, X., Zhang, Y., Fu, Y., Zhang, H., Li, H.-X., Li, Q., Li, H., Tan, R., Jiang, C.-X., Jiang, W., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00605-0 · Cited by 18
Zhang, B., Au, Q., Yoon, I. S., Tremblay, M.-H., Yip, G., Zhou, Y., Barber, J. R., & Ng, S. C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.079 · Cited by 17
Binding Modes of Phthalocyanines to Amyloid β Peptide and Their Effects on Amyloid Fibril Formation
Valiente‐Gabioud, A. A., Riedel, D., Outeiro, T. F., Menacho-Márquez, M., Griesinger, C., & Fernández, C. O. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.01.003 · Cited by 18
Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation
Bhasne, K., & Mukhopadhyay, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201800059 · Cited by 18
Coagulansin-A improves spatial memory in 5xFAD Tg mice by targeting Nrf-2/NF-κB and Bcl-2 pathway
Shal, B., Khan, A., Khan, A. U., Ullah, R., Naveed, M., Ali, G., Islam, S. U., Haq, I. U., Mirza, B., & Khan, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108860 · Cited by 17
Taneva, S. G., Todinova, S. J., & Andreeva, T. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814296 · Cited by 18
Conformational changes of Aβ (1–42) monomers in different solvents
Lee, M., Chang, H. J., Park, J. Y., Shin, J., Park, J. W., Choi, J. W., Kim, J. I., & Na, S. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.02.003 · Cited by 16
Yeast as a Platform to Explore Polyglutamine Toxicity and Aggregation
Duennwald, M. L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-438-8_11 · Cited by 16
A decay of the adaptive capacity of the unfolded protein response exacerbates Alzheimer's disease
Gerakis, Y., & Hetz, C. A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.012 · Cited by 16
“These diseases are now classified as protein-misfolding disorders (PMDs) and include Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and Alzheimer’s disease (AD) among others (Soto, 2003).”
BackgroundNanoclay based study on protein stability and aggregation and its implication in human health
Parveen, R., Tarannum, Z., Ali, S., & Fatima, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.197 · Cited by 17
Don, E. K., Maschirow, A., Radford, R. A. W., Scherer, N. M., Vidal-Itriago, A., Hogan, A. L., Maurel, C., Formella, I., Stoddart, J. J., Hall, T. E., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02238-0 · Cited by 17
“Protein misfolding and aggregation are hallmarks of many different neurodegenerative diseases, however the precise mechanisms linking protein aggregation and neurotoxicity are largely unknown (reviewed in [1],[2],[3]).”
BackgroundNiu, H., Hou, X., Zhang, Y., Wu, X., Dèng, F., Huang, F., Shi, L., & Ma, R. (2021) · ACS Macro Letters · doi:10.1021/acsmacrolett.1c00200 · Cited by 18
Bahramikia, S., Yazdanparast, R., & Gheysarzadeh, A. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01391.x · Cited by 16
Psychiatry and Neuroscience Update: Bridging the Divide
Perez‐Lloret, S., Peralta, M. C., & Barrantes, F. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17103-6 · Cited by 17
Analysis of [SWI+] formation and propagation events
Du, Z., Goncharoff, D. K., Cheng, X., & Li, L. (2016) · Molecular Microbiology · doi:10.1111/mmi.13616 · Cited by 18
“Besides PrP, amyloid architecture is shared by a large number of other pathogenic proteins, including asynuclein, b-amyloid, tau and TDP-43, each of which is tightly linked to a fatal, devastating neurodegenerative disease (Soto, 2003; Aguzzi and O’Connor, 2010; Eisenberg and Jucker, 2012).”
BackgroundRNA Aptamers Rescue Mitochondrial Dysfunction in a Yeast Model of Huntington’s Disease
Patel, K. A., Chaudhary, R. K., & Roy, I. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.010 · Cited by 16
Paul, A. D., & Natarajan, H. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00857-9 · Cited by 15
“[ 77] Dysbiosis is the cause of lowered production of these helpful metabolites, thereby, metabolic dysregulation and increased inflammation will occur.”
Zuo, K., Kranjc, A., Capelli, R., Rossetti, G., Nechushtai, R., & Carloni, P. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp01388j · Cited by 15
Hemagirri, M., Chen, Y., Gopinath, S. C. B., Sahreen, S., Adnan, M., & Sasidharan, S. (2023) · Biochimie · doi:10.1016/j.biochi.2023.10.019 · Cited by 17
Ngwa, H. A., Bargues-Carot, A., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105285 · Cited by 15
Walker, A. C., Bhargava, R., Bucher, M. J., Argote, Y. M., Brust, A. S., & Czyż, D. M. (2024) · iScience · doi:10.1016/j.isci.2024.110828 · Cited by 15
Inflammation and heterogeneity in synucleinopathies
Freuchet, A., Pinçon, A., Sette, A., & Arlehamn, C. S. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432342 · Cited by 16
Chang, H. J., Baek, I., Lee, M., & Na, S. (2015) · ChemPhysChem · doi:10.1002/cphc.201500244 · Cited by 15
Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders
Cohen, E., Moll, L., & Elami, T. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13917 · Cited by 17
Lee, M., & Na, S. (2015) · ChemPhysChem · doi:10.1002/cphc.201500945 · Cited by 15
He, B., Zheng, M., Liu, Q., Shi, Z., Long, S., Lu, X.-L., Pei, Z., Yuan, T., Su, H., & Yao, X. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0446-1 · Cited by 17
Chae, C., Seo, H., Bak, I.-G., & Lee, J. (2018) · Macromolecules · doi:10.1021/acs.macromol.7b02619 · Cited by 15
Ding, L., Nan, W., Zhu, X., Li, X., Zhou, L., Chen, H., Yu, L., Khan, F. U., Zhong, H., & Shi, X. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13062 · Cited by 15
Impairment of autophagy in scrapie-infected transgenic mice at the clinical stage
López-Pérez, Ó., Toivonen, J. M., Otero, A., Solanas, L., Zaragoza, P., Badiola, J. J., Osta, R., Bolea, R., & Martín‐Burriel, I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0312-z · Cited by 16
Andrade‐Restrepo, M., Ciuperca, I. S., Lemarre, P., Pujo-Menjouet, L., & Tine, L. M. (2021) · Journal of Mathematical Biology · doi:10.1007/s00285-021-01593-3 · Cited by 15
Moreno‐González, I., Edwards, G. A., Morales, R., Duran-Aniotz, C. A., Escobedo, G., Márquez, M., Pumarola, M. B., & Soto, C. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.815361 · Cited by 15
“Although the etiology of AD is not yet clear, extensive evidence suggests that the central pathological event is the misfolding, aggregation and brain deposition of Aβ and tau (Soto, 2003; Huang and Mucke, 2012; Masters and Selkoe, 2012).”
BackgroundSelf-citationLi, D., Johmura, Y., Morimoto, S., Doi, M., Nakanishi, K., Ozawa, M., Tsunekawa, Y., Inoue‐Yamauchi, A., Naruse, H., Matsukawa, T., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00464-4 · Cited by 17
“In addition, a total of 158 Japanese patients with SCD presenting with cerebellar ataxia of unknown etiologies were recruited for the whole-exome sequence analysis as described above with the following inclusion criteria: (1) progressive ataxia; (2) secondary ataxias due to cerebrovascular diseases, tumor, alcohol abu…”
MethodMeratan, A. A., & Nemat‐Gorgani, M. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.04.020 · Cited by 16
“Indeed many recent findings have demonstrated mitochondrial malfunction is the earliest and the most specific character of a wide range of neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis (ALS) [10].”
BackgroundPhased Fiber Growth in a Peptide Conjugate: Aggregation and Disaggregation Studies
Ghosh, S., & Verma, S. K. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp066546a · Cited by 15
Zhang, Y., Chang, F.-M., Huang, J., Junco, J. J., Maffi, S. K., Pridgen, H. I., Catano, G., Dang, H., Ding, X. D., Yang, F., et al. (2014) · Protein & Cell · doi:10.1007/s13238-013-0018-8 · Cited by 21
“Oxidative modification of proteins causes a conformational change and structural unfolding, leading to a loss of protein function (Davies and Delsignore, 1987; Soto, 2003).”
BackgroundFirst passage times in homogeneous nucleation: Dependence on the total number of particles
Yvinec, R., Bernard, S., Hingant, E., & Pujo-Menjouet, L. (2016) · The Journal of Chemical Physics · doi:10.1063/1.4940033 · Cited by 15
Lin, Y., Komatsu, H., Ma, J., Axelsen, P. H., & Fakhraai, Z. (2016) · RSC Advances · doi:10.1039/c6ra24031c · Cited by 15
U1 small nuclear RNA overexpression implicates autophagic-lysosomal system associated with AD
Cheng, Z., Du, Z., Zhai, B., Yang, Z. R., & Zhang, T. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.01.006 · Cited by 17
“…ative diseases (e.g. AD), several mutations of the pathogenic gene induce not only positive symptoms but also anomalous conformations of the encoded protein or their metabolites, then lead to increase proteolytic resistance and accumulation of these potentially toxic proteins (Soto, 2003).”
BackgroundEffects of nanobubbles on peptide self-assembly
Wang, Y., Shen, Z., Guo, Z., Hu, J., & Zhang, Y. (2018) · Nanoscale · doi:10.1039/c8nr06142d · Cited by 15
Verheijen, B. M., Lussier, C., Müller-Hübers, C., Garruto, R. M., Oyanagi, K., Braun, R. J., & van Leeuwen, F. W. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz110 · Cited by 19
Guijarro, I. M., Garcés, M., Andrés‐Benito, P., Marín, B., Otero, A., Barrio, T., Carmona, M., Ferrer, I., Badiola, J. J., & Monzón, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093231 · Cited by 15
Protein Aggregates in Pathological Inclusions of Amyotrophic Lateral Sclerosis
Furukawa, Y. (2012) · InTech eBooks · doi:10.5772/30897 · Cited by 17
“10 nm (Soto, 2003).”
Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis
Walker, A. C., Bhargava, R., Dove, A. S., Brust, A. S., Owji, A. A., & Czyż, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094807 · Cited by 18
“Neurodegenerative protein conformational diseases (PCDs) are disorders of protein homeostasis (proteostasis) and subsequent protein folding capacity, hallmarked by the accumulation of metastable proteins into insoluble aggregates [1].”
BackgroundGupta, N., Quazi, S., Jha, S. K., Siddiqi, M. K., Verma, K., Sharma, S. K., Khan, R. H., & Bhagyawant, S. S. (2022) · Nutrients · doi:10.3390/nu14224824 · Cited by 14
“In Alzheimer’s diseases, theses aggregates target the brain cells, while in type II diabetes, they remain concentrated in pancreatic tissues leading to β-cell dysfunction [4,5].”
RetractedTDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport
Wu, H., Wang, L. C., Sow, B. M., Leow, D., Zhu, J., Gallo, K. M., Wilsbach, K., Gupta, R., Ostrow, L., Yeo, C. J. J., et al. (2024) · bioRxiv · doi:10.1038/s41467-024-52706-7 · Cited by 18
“It has been questioned whether protein aggregation is the cause or result of cellular dysfunction and whether aggregation is protective against proteotoxic damages 21,102 – 107 .”
Côté, S., Wei, G., & Mousseau, N. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp306661c · Cited by 14
Identification of an RNA Polymerase III Regulator Linked to Disease-Associated Protein Aggregation
Sin, O., de Jong, T. V., Mata‐Cabana, A., Kudron, M. M., Zaini, M. A., Aprile, F. A., Seinstra, R. I., Stroo, E., Prins, R. W., Martineau, C. N., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.022 · Cited by 15
“1096 Molecular Cell 65, 1096–1108, March 16, 2017 a 2017 The Auth This is an open access article under the CC BY-NC-ND license (http:// presence of protein aggregates in different brain areas of affected patients (Soto, 2003).”
BackgroundCell-free amplification of prions: Where do we stand?
Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14
Ghosh, R., & Kishore, N. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c06167 · Cited by 14
Manole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 15
“In vitro studies have shown that alpha-synuclein can aggregate, forming amyloid fibres or fibrils with a cross-beta structure (Conway et al., 1998; Greenwald and Riek, 2010; Soto, 2003).”
BackgroundKhandia, R., Sharma, A., Alqahtani, T., Alqahtani, A., Asiri, Y. I., Alqahtani, S., Alharbi, A. M., & Kamal, M. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.887929 · Cited by 14
“Many neurodegenerative disorders have shown an association with misfolding of proteins and their aggregation in specific brain regions (Soto, 2003).”
BackgroundImmunolocalization of Tom1 in relation to protein degradation systems in Alzheimer's disease
Makioka, K., Yamazaki, T., Takatama, M., Ikeda, M., Murayama, S., Okamoto, K., & Ikeda, Y. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.035 · Cited by 15
“The regional distribution in the central nervous system and the composition of protein aggregates are different in each neurodegenerative disease [6].”
BackgroundBandehagh, A., Noparvar, P. M., & Uliaie, E. D. (2013) · Cited by 14
Targeting mRNA translation in Parkinson’s disease
Correddu, D., & Leung, I. K. H. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.04.003 · Cited by 17
Jayaraj, R. L., & Elangovan, N. (2014) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2014.01.002 · Cited by 14
Activation and alteration of lysosomes in multiple system atrophy
Makioka, K., Yamazaki, T., Takatama, M., Nakazato, Y., & Okamoto, K. (2012) · Neuroreport · doi:10.1097/wnr.0b013e3283503e4f · Cited by 16
Recent progress of dual-responsive fluorescent probes for polarity and analytes
He, J., Han, X., & Yue, Y. (2025) · The Analyst · doi:10.1039/d5an00243e · Cited by 15
Glass, K. A., Giloteaux, L., Zhang, Z., & Hanson, M. R. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70346 · Cited by 16
“88,89 Increased levels of PDIs have been observed in the spinal cord and cerebrospinal fluid of ALS patients.”
Amyloid‐Like Assembly to Form Film at Interfaces: Structural Transformation and Application
Han, Q., Tao, F., & Yang, P. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300172 · Cited by 13
AI-Driven Drug Discovery and Development
Afrose, N., Chakraborty, R., Hazra, A., Bhowmick, P., & Bhowmick, M. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-3629-8.ch013 · Cited by 16
Ibrahim, K. A., Cathala, C., Bevilacqua, C., Feletti, L., Prevedel, R., Lashuel, H. A., & Rađenović, A. (2025) · Nature Communications · doi:10.1038/s41467-025-60912-0 · Cited by 14
“…is the hallmark of various neurodegenerative diseases (NDDs), including Huntington ’ s disease (HD), which is caused by an abnormal polyglutamine (polyQ) expansion in the fi rst exon of the Huntingtin (Htt) protein (Httex1), leading to its increased propensity to misfold and aggregate 1 – 4 .”
The effect of structural heterogeneity on the conformation and stability of Aβ–tau mixtures
Choi, H., Lee, M., Park, H. S., & Na, S. (2016) · RSC Advances · doi:10.1039/c6ra09467h · Cited by 13
Bernardo, M. D., & Carlo, M. D. (2017) · InTech eBooks · doi:10.5772/intechopen.70301 · Cited by 16
“Even though their clinical manifestations and symptoms are completely different, neurodegenerative disorders share some common features, such as their appearance with aging, neuronal loss and synaptic anomalies, and mainly the presence of cerebral deposits of misfolded protein aggregates [32].”
BackgroundModeling the spatial propagation of Aβ oligomers in Alzheimer’s Disease
Andrade‐Restrepo, M., Lemarre, P., Pujo-Menjouet, L., Tine, L. M., & Ciuperca, I. S. (2020) · ESAIM Proceedings and Surveys · doi:10.1051/proc/202067003 · Cited by 13
“As is the case for these other diseases, AD is associated with the misconformation, aggregation and propagation of different proteins in the neural system [24], namely the proteins Aβ and tau.”
BackgroundModulation of bovine serum albumin aggregation by glutathione functionalized MoS2 quantum dots
Zeng, H., Sun, L., Qu, L., & Yang, R. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.005 · Cited by 13
Increase of autophagy marker p62 in the placenta from pregnant women with preeclampsia
Ribeiro, V. R., Romão‐Veiga, M., Nunes, P. R., Peraçoli, J. C., & Peraçoli, M. T. S. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.02.005 · Cited by 14
Halder, B., Mitra, A., Dewangan, S., Gazi, R., Sarkar, N., Jana, M., & Chatterjee, S. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134362 · Cited by 13
Dar, G. H., Badierah, R., Nathan, E., Bhat, M. A., Dar, A. H., & Redwan, E. M. M. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.967231 · Cited by 14
“Despite the fact that the distinctive proteins are involved in various NDs, the process of protein misfolding, their intermediates and end-products are mostly similar, which has provided in-depth understanding about overlapping disease mechanisms in patients with sporadic and inherited neurodegenerative disease (Soto,…”
BackgroundSaini, R., Navale, G. R., Singh, S., Singh, H. K., Chauhan, R., Agrawal, S., Sarkar, D. M., Sarma, M., & Ghosh, K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125847 · Cited by 14
Moschus ameliorates glutamate-induced cellular damage by regulating autophagy and apoptosis pathway
Xie, D., Song, C., Qin, T., Zhai, Z., Cai, J., Dai, J., Sun, T., & Xu, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-45878-7 · Cited by 16
“Autophagy is essential in neuronal homeostasis, and its dysfunction is directly related to neurodegenerative diseases 65–67 .”
Label-Free Measurement of Amyloid Elongation by Suspended Microchannel Resonators
Wang, Y., Modena, M. M., Platen, M., Schaap, I. A. T., & Burg, T. P. (2014) · Analytical Chemistry · doi:10.1021/ac503845f · Cited by 13
Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases
You, H. J., Park, J. H., Pareja-Galeano, H., Lucía, A., & Shin, J. I. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8407-9 · Cited by 15
“…share common pathological phenotypes such as compromised autophagy (Menzies et al. 2015), accumulation of misfolded and aggregated proteins (Soto 2003), and oxidative stress due to toxic reactive oxygen species (Barnham et al. 2004), which lead to impairments in neurotransmission ,…”
BackgroundMining databases for protein aggregation: a review
Tsiolaki, P. L., Nastou, K. C., Hamodrakas, S. J., & Iconomidou, V. A. (2017) · Amyloid · doi:10.1080/13506129.2017.1353966 · Cited by 13
Siddiqui, M. F., & Bano, B. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.172 · Cited by 13
“Prions as well as misfolded proteins are the major foundations of various animal neurodegenerative diseases [18,19].”
Schiavone, N. M., Pirrone, G. F., Guetschow, E. D., Mangion, I. K., & Makarov, A. A. (2018) · Talanta · doi:10.1016/j.talanta.2018.09.077 · Cited by 13
Wang, S., Meng, F., Hao, R., Wang, C., & Li, F. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183108 · Cited by 13
Jahan, I., & Nayeem, S. M. (2021) · New Journal of Chemistry · doi:10.1039/d1nj04453b · Cited by 13
Cyclic Amplification of Prion Protein Misfolding
Castilla, J., Saá, P., & Soto, C. A. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7949-1_14 · Cited by 14
Self-citationSpectroscopic investigation on the interaction of Cr(VI) with bovine serum albumin
Zhang, P., Lan, P., Yue-ning, M., Gao, Y., Chen, H., Fang, Q., Zong, W., & Liu, R. (2011) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20398 · Cited by 13
“Once the protein’s structure is changed or destroyed, namely protein denaturation [1], the corresponding functions will be reduced or lost, leading to the functions disorder and illness occurrence [2].”
BackgroundOno, K., Noguchi‐Shinohara, M., Yoshita, M., Naiki, H., & Yamada, M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.012 · Cited by 13
Retracted
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.